Outcome of children with first relapse of Hodgkin's disease. A report from the Societe Francaise des Cancers de l'Enfant (SFCE)

被引：0

作者：

Gorde-Grosjean, S. ^{[1
]}

Ansoborlo, S.

Pacquement, H. ^{[2
]}

Lambilliot, A. ^{[3
]}

Michel, G. ^{[4
]}

Oberlin, O. ^{[5
]}

Leblanc, T. ^{[6
]}

Perel, Y. ^{[7
]}

Schell, M. ^{[8
]}

Leverger, G. ^{[9
]}

Landman-Parker, J. ^{[9
]}

机构：

[1] CHU Reims, Serv Hematol Pediat, Reims, France

[2] Inst Curie, Serv Pediat, F-75231 Paris, France

[3] CHU Lille, Serv Hematol Pediat, Lille, France

[4] CHU Marseille, Serv Hematol Pediat, Marseille, France

[5] Inst Gustave Roussy, Serv Pediat, Villejuif, France

[6] CHU St Louis, Serv Pediat, Paris, France

[7] CHU Bordeaux, Serv Hematol Pediat, Paris, France

[8] Ctr Leon Berard, Serv Pediat, Lyon, France

[9] Hop Trousseau, Serv Hematol Pediat, Paris, France

来源：

HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2007年 / 92卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：59 / 60

页数：2

共 38 条

[21] Prise en charge des toxicites de la pegaspargase (hors anomalies de la coagulation). Recommandations du comite leucemie de la Societe francaise de lutte contre les cancers de l'enfant et de l'adolescent
Poiree, Marilyne
Neumann, Florent
Thomas, Caroline
Simon, Pauline
Lunven, Anne France Ray
Plantaz, Dominique
Doulet, Sandrine Thouvenin
Strullu, Marion
BULLETIN DU CANCER, 2022, 109 (11) : 1125 - 1131
[22] Phase II study of temozolomide in relapsed or refractory high-risk neuroblastoma: A Joint Societe' Francaise des Cancers de l'Enfant and United Kingdom Children Cancer Study Group-New Agents Group Study
Rubie, Herve
Chisholm, Julia
Defachelles, Anne Sophie
Morland, Bruce
Munzer, Caroline
Valteau-Couanet, Dominique
Mosseri, Veronique
Bergeron, Christophe
Weston, Clare
Coze, Carole
Auvrignon, Anne
Djafari, Latifa
Hobson, Rachel
Baunin, Christiane
Dickinson, Fiona
Brisse, Herve
McHugh, Kieran
Biassoni, Lorenzo
Giammarile, Francesco
Vassal, Gilles
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (33) : 5259 - 5264
[23] Autotransplants for Hodgkin's disease in first relapse or second remission: a report from the autologous blood and marrow transplant registry (ABMTR)
HM Lazarus
FR Loberiza
M-J Zhang
JO Armitage
KK Ballen
A Bashey
BJ Bolwell
LJ Burns
CO Freytes
RP Gale
J Gibson
RH Herzig
CF LeMaistre
D Marks
J Mason
AM Miller
GA Milone
S Pavlovsky
DE Reece
JD Rizzo
K van Besien
JM Vose
MM Horowitz
Bone Marrow Transplantation, 2001, 27 : 387 - 396
[24] Autotransplants for Hodgkin's disease in first relapse or second remission: a report from the autologous blood and marrow transplant registry (ABMTR)
Lazarus, HM
Loberiza, FR
Zhang, MJ
Armitage, JO
Ballen, KK
Bashey, A
Bolwell, BJ
Burns, LJ
Freytes, CO
Galeg, RP
Gibson, J
Herzig, RH
LeMaistre, CF
Marks, D
Mason, J
Miller, AM
Milone, GA
Pavlovsky, S
Reece, DE
Rizzo, JD
van Besien, K
Vose, JM
Horowitz, MM
BONE MARROW TRANSPLANTATION, 2001, 27 (04) : 387 - 396
[25] The impact of disease status at transplant and time to first relapse on outcome in children and adolescents with Hodgkin's lymphoma undergoing autologous stem cell transplantation.
Claviez, A
Kabisch, H
Suttorp, M
Peters, C
Hero, B
Schiller, I
Doerffel, W
Schmitz, N
Zintl, F
BLOOD, 2004, 104 (11) : 520A - 520A
[26] Late effects of allogeneic bone marrow transplantation for children with acute myeloblastic leukemia in first complete remission: The impact of conditioning regimen without total-body irradiation - A report from the Societe Francaise de Greffe de Moelle
Michel, G
Socie, G
Gebhard, F
Bernaudin, F
Thuret, I
Vannier, JP
Demeocq, F
Leverger, G
Pico, JL
Rubie, H
Mechinaud, F
Reiffers, J
Gratecos, N
Troussard, X
Jouet, JP
Simonin, G
Gluckman, E
Maraninchi, D
JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (06) : 2238 - 2246
[27] ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR CHILDREN WITH ACUTE MYELOBLASTIC-LEUKEMIA IN FIRST COMPLETE REMISSION - IMPACT OF CONDITIONING REGIMEN WITHOUT TOTAL-BODY IRRADIATION - A REPORT FROM THE SOCIETE-FRANCAISE-DE-GREFFE-DE-MOELLE
MICHEL, G
GLUCKMAN, E
ESPEROUBOURDEAU, H
REIFFERS, J
PICO, JL
BORDIGONI, P
THURET, I
BLAISE, D
BERNAUDIN, F
JOUET, JP
LEMERLE, S
RUBIE, H
MILPIED, N
VANNIER, JP
DEMEOCQ, F
TROUSSARD, X
GRATECOS, N
PLOUVIER, E
BERGERON, C
GARDEMBAS, M
GOUVERNET, J
MARANINCHI, D
JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (06) : 1217 - 1222
[28] Reduced-intensity conditioning followed by allogeneic transplantation in pediatric malignancies: a report from the Société Française des Cancers de l’Enfant and the Société Française de Greffe de Moelle et de Thérapie Cellulaire
C Paillard
E Rochette
P Lutz
Y Bertrand
G Michel
P Bordigoni
J H Dalle
P Rohrlich
J P Vannier
Y Perel
D Plantaz
G Leverger
A Sirvent
E Dore
F Isfan
E Merlin
B Pereira
P Halle
N Rabiau
J Kanold
F Deméocq
Bone Marrow Transplantation, 2013, 48 : 1401 - 1408
[29] Plasma cytokine and soluble receptor signature predicts outcome of patients with classical Hodgkin's lymphoma:: A study from the Groupe d'Etude des Lymphomes de l'Adulte
Casasnovas, Rene-Olivier
Mounier, Nicolas
Brice, Pauline
Divine, Marine
Morschhauser, Franck
Gabarre, Jean
Blay, Jean-Yves
Voillat, Laurent
Lederlin, Pierre
Stamatoullas, Aspasia
Bienvenu, Jacques
Guiguet, Michel
Intrator, Liliane
Grandjean, Monique
Briere, Josette
Ferme, Christophe
Salles, Gilles
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (13) : 1732 - 1740
[30] Impact of conditionning regimen in allogeneic hematopoietic stem cell transplantation for children with acute myeloid leukemia in first complete remission: Total-body irradiation and cyclophosphamide versus busulfan and cyclophosphamide - A report from The Societe Francaise de Greffe de Moelle et de Therapie Cellulaire
Dalle, Jean-Hugues
Caty, Luc
Peffault, Regis
Salmon, Alexandra
Mialou, Valerie
Galambrun, Claire
Yakouben, Karima
Mechinaud, Francoise
Bordigoni, Pierre
BLOOD, 2007, 110 (11) : 190A - 191A

← 1 2 3 4 →